...
首页> 外文期刊>形成外科 >CD10,CD99の免疫組織学的検討を行ったatypical fibroxanthomaの1例
【24h】

CD10,CD99の免疫組織学的検討を行ったatypical fibroxanthomaの1例

机译:通过免疫组织学检查CD10和CD99的一例非典型纤维黄瘤

获取原文
获取原文并翻译 | 示例
           

摘要

The patient was a 56-year-old man who had a 1cm nodule on his left cheek. The tumor was simply excised at the former hospital, but two months after that excision, recurrence resulted. Then, in our hospital, this lesion was removed on the surface of the muscle with surgical margin of about lcm and trilobed flap was used for wound closure. The pathological diagnosis was recurrent atypical fibroxanthoma. After the operation, we examined immunoreactivity to CD10 and CD99 for a specimen of the simple excision. For 10 months after our surgery, there was no recurrence or metastasis.Atypical fibroxanthoma occurs mostly on the head and neck of elderly people. It is characterized as following a benign clinical course despite its histological appearance.Histological differential diagnoses for atypical fibroxanthoma include malignant fibrous histiocytoma, squamous cell carcinoma, and malignant melanoma. Recently, immu no hi sto chemical markers CD10 and CD99 are thought to be useful in diagnosis.
机译:该患者是一个56岁的男人,左颊上有一个1cm的结节。只是在原医院切除了肿瘤,但切除后两个月就复发了。然后,在我们医院,以约1cm的手术切缘在肌肉表面去除该病灶,并用三叶瓣封闭伤口。病理诊断为复发性非典型纤维性黄瘤。手术后,我们检查了简单切除标本对CD10和CD99的免疫反应性。手术后10个月没有复发或转移,非典型纤维性黄瘤通常发生在老年人的头和颈部。尽管具有组织学外观,但其特征是遵循良性临床过程。非典型纤维黄瘤的组织学鉴别诊断包括恶性纤维组织细胞瘤,鳞状细胞癌和恶性黑色素瘤。最近,人们认为免疫原性化学标记CD10和CD99可用于诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号